Numerous studies have examined the expression of several CYP isoforms in breast cancer, including aromatase/CYP19A1 (Suzuki et al., 2009), CYP1A1 (Androutsopoulos et al., 2009; Rodriguez and Potter, 2013), CYP1B1 (McKay et al., 1995; Murray et al., 1997), CYP2J2 (Jiang et al., 2009; Murray et al., 2010), CYP2C (Huang et al., 1996; Murray et al., 2010), CYP3A (Huang et al., 1996), and the CYP4 family (Rieger et al., 2004; Alexanian et al., 2012). This evidence concerns the gene CYP19A1 and breast carcinoma.